MX2011011885A - Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dime thyl-butyramide. - Google Patents

Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dime thyl-butyramide.

Info

Publication number
MX2011011885A
MX2011011885A MX2011011885A MX2011011885A MX2011011885A MX 2011011885 A MX2011011885 A MX 2011011885A MX 2011011885 A MX2011011885 A MX 2011011885A MX 2011011885 A MX2011011885 A MX 2011011885A MX 2011011885 A MX2011011885 A MX 2011011885A
Authority
MX
Mexico
Prior art keywords
dimethyl
morpholin
phenyl
butyramide
stable forms
Prior art date
Application number
MX2011011885A
Other languages
Spanish (es)
Inventor
Heidi Lopez De Diego
Svend Treppendahl
Karin Liltorp
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42237259&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2011011885(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MX2011011885A publication Critical patent/MX2011011885A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

Polymorphic forms of N-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl- butyramideare provided together with a process for the manufacture of said compound.
MX2011011885A 2009-05-11 2010-05-11 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dime thyl-butyramide. MX2011011885A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200900597 2009-05-11
PCT/DK2010/050101 WO2010130260A2 (en) 2009-05-11 2010-05-11 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dimethyl-butyramide

Publications (1)

Publication Number Publication Date
MX2011011885A true MX2011011885A (en) 2011-12-06

Family

ID=42237259

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011011885A MX2011011885A (en) 2009-05-11 2010-05-11 Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dime thyl-butyramide.

Country Status (23)

Country Link
EP (1) EP2430008A2 (en)
JP (1) JP2012526152A (en)
KR (1) KR20120022934A (en)
CN (1) CN102459208A (en)
AR (1) AR076556A1 (en)
AU (1) AU2010246724B2 (en)
BR (1) BRPI1013930A2 (en)
CA (1) CA2761383A1 (en)
CL (1) CL2011002814A1 (en)
CO (1) CO6460741A2 (en)
CR (1) CR20110590A (en)
DO (1) DOP2011000351A (en)
EA (1) EA201171381A1 (en)
GE (1) GEP20146006B (en)
IL (1) IL216148A0 (en)
MA (1) MA33351B1 (en)
MX (1) MX2011011885A (en)
NZ (1) NZ596738A (en)
SG (1) SG175968A1 (en)
TN (1) TN2011000557A1 (en)
TW (1) TW201041857A (en)
WO (1) WO2010130260A2 (en)
ZA (1) ZA201108112B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI349666B (en) * 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives
CN101563085A (en) * 2006-08-23 2009-10-21 威朗国际制药公司 Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US20100256145A1 (en) * 2007-08-01 2010-10-07 H. Lundbeck A/S Use of kcnq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted

Also Published As

Publication number Publication date
WO2010130260A2 (en) 2010-11-18
AU2010246724A1 (en) 2011-12-08
BRPI1013930A2 (en) 2019-09-24
SG175968A1 (en) 2011-12-29
WO2010130260A9 (en) 2012-10-18
GEP20146006B (en) 2014-01-10
CO6460741A2 (en) 2012-06-15
DOP2011000351A (en) 2012-01-31
MA33351B1 (en) 2012-06-01
EP2430008A2 (en) 2012-03-21
JP2012526152A (en) 2012-10-25
TN2011000557A1 (en) 2013-05-24
AU2010246724B2 (en) 2013-03-21
KR20120022934A (en) 2012-03-12
WO2010130260A3 (en) 2011-06-16
CA2761383A1 (en) 2010-11-18
NZ596738A (en) 2013-04-26
AR076556A1 (en) 2011-06-22
TW201041857A (en) 2010-12-01
CR20110590A (en) 2012-02-22
ZA201108112B (en) 2013-01-30
CN102459208A (en) 2012-05-16
EA201171381A1 (en) 2012-05-30
CL2011002814A1 (en) 2012-04-13
IL216148A0 (en) 2012-01-31

Similar Documents

Publication Publication Date Title
TN2011000286A1 (en) Spiroheterocyclic n-oxypiperidines as pesticides
PT2509958E (en) Azole derivatives, methods for producing the same, intermediates thereof, agro-horticultural agents
EP2361902A4 (en) 4,6-diaminonicotinamide compound
ZA201008056B (en) Indoleamine 2,3-dioxygenase based immunotherapy
UA100521C2 (en) Salts of bazedoxifene
RS52255B (en) Nalmefene hydrochloride dihydrate
IN2015DN01331A (en)
ZA201103390B (en) Process for the manufacture of p4o6 with high yield
IL214110A0 (en) 2,3-diaryl-or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
EP2883870B8 (en) Method for producing 1,4-benzoxazine compound
ZA201004118B (en) Process for the production of 1,2-propanediol
WO2011134724A3 (en) Method for preparing ritodrine hydrochloride
HK1162032A1 (en) 1,1,1-trifluoro-2-hydroxypropyl compounds 111--2-
MX2011011885A (en) Stable forms of n-(2,6-dimethyl-4-morpholin-4-yl-phenyl)-3,3-dime thyl-butyramide.
IL206886A0 (en) Process for the manufacture of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative
UA27272U (en) Use of yakton as cardioprotector
UA51468U (en) Holder for soother
UA35142U (en) Feed additive
MX2009012727A (en) Process for preparing benzyl pentahydroxyhexylcarbamoylundecanoat e.
HU0501156D0 (en) Process for the production of 15-alpha-hydroxylevodion by bioconversion
ITRA20060009U1 (en) MACHINE FOR THE PRODUCTION OF ICICLES.
ITRA20060008U1 (en) MACHINE FOR THE PRODUCTION OF ICICLES.
MX2013004722A (en) Crystalline form of 13-[(n-tert-butoxycarbonyl)-2'-o-hexanoyl-3-p henylisoserinyl]-10-deacetylbaccatin iii.
TH112948B (en) A procedure for the production of one or more ethylene derivative compounds.

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal